NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Scientific Advisory Board as It Advances Product Development, Clinical and Commercial Efforts

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced the expansion of its scientific advisory board (“SAB”) to include several leading cardiologists. New members include Charles L. Brown III, MD, CEO of the Piedmont Healthcare Physician Enterprise, Tony Das, MD, a nationally recognized board-certified interventional cardiology specialist, leader and educator in the field of cardiovascular diseases, Robert Harrington, MD, dean of Weill Cornell Medicine and provost for medical affairs of Cornell University, Campbell Rogers, MD, EVP and chief medical officer at HeartFlow Inc., and Niraj Varma, MD, Ph.D., professor of medicine and consultant electrophysiologist at the Cleveland Clinic. “We are honored and pleased to have such a distinguished group of physicians joining our scientific advisory board,” said Branislav Vajdic, Ph.D., CEO and founder of HeartBeam. “HeartBeam will benefit tremendously from the input of these leaders in interventional cardiology, electrophysiology, clinical research, and new technologies. We look forward to working closely with all the SAB members as we advance our product development, clinical and commercial efforts.”

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer